Found: 84
Select item for more details and to access through your institution.
Unsupervised exercise in survivors of human papillomavirus related head and neck cancer: how many can go it alone?
- Published in:
- 2017
- By:
- Publication type:
- journal article
Personal Income Tax Gap for Business Income Earners in New York State: From the Real Estate Tax Perspective.
- Published in:
- Journal of State Taxation, 2011, v. 29, n. 6, p. 27
- By:
- Publication type:
- Article
The association between fatigue and pain symptoms and decreased physical activity after cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Immune Therapy Targeting E6/E7 Oncogenes of Human Papillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory Papillomatosis.
- Published in:
- Vaccines, 2020, v. 8, n. 1, p. 56, doi. 10.3390/vaccines8010056
- By:
- Publication type:
- Article
Letters.
- Published in:
- 1993
- By:
- Publication type:
- Letter
Reversible neurologic toxicity in patients treated with standard-dose fludarabine phosphate for mycosis fungoides and chronic lymphocytic leukemia.
- Published in:
- 1993
- By:
- Publication type:
- journal article
The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer.
- Published in:
- Biologics: Targets & Therapy, 2010, v. 4, p. 173
- By:
- Publication type:
- Article
Nonsurgical management of oropharyngeal, laryngeal, and hypopharyngeal cancer: The Fox Chase Cancer Center experience.
- Published in:
- Head & Neck, 2011, v. 33, n. 10, p. 1433, doi. 10.1002/hed.21615
- By:
- Publication type:
- Article
Impact of neck dissection on long-term feeding tube dependence in patients with head and neck cancer treated with primary radiation or chemoradiation.
- Published in:
- Head & Neck, 2010, v. 32, n. 3, p. 341, doi. 10.1002/hed.21188
- By:
- Publication type:
- Article
Fluorescence in situ hybridization gene amplification analysis of EGFR and HER2 in patients with malignant salivary gland tumors treated with lapatinib.
- Published in:
- Head & Neck, 2009, v. 31, n. 8, p. 1006, doi. 10.1002/hed.21052
- By:
- Publication type:
- Article
A Pilot Study of Sequential Therapy with Zidovudine plus Acyclovir, Dideoxyinosine, and Dideoxycytidine in Patients with Severe Human Immunodeficiency Virus Infection.
- Published in:
- Journal of Infectious Diseases, 1993, v. 168, n. 4, p. 810, doi. 10.1093/infdis/168.4.810
- By:
- Publication type:
- Article
Phase Ib study of pevonedistat, a NEDD8-activating enzyme inhibitor, in combination with docetaxel, carboplatin and paclitaxel, or gemcitabine, in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 1, p. 87, doi. 10.1007/s10637-018-0610-0
- By:
- Publication type:
- Article
A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 5, p. 576, doi. 10.1007/s10637-017-0459-7
- By:
- Publication type:
- Article
Erratum to: A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors.
- Published in:
- 2017
- By:
- Publication type:
- Erratum
Phase I dose escalation and pharmacokinetic evaluation of two different schedules of LY2334737, an oral gemcitabine prodrug, in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 6, p. 1206, doi. 10.1007/s10637-015-0286-7
- By:
- Publication type:
- Article
A multicenter phase 1 study of PX-866 and cetuximab in patients with metastatic colorectal carcinoma or recurrent/metastatic squamous cell carcinoma of the head and neck.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 6, p. 1197, doi. 10.1007/s10637-014-0124-3
- By:
- Publication type:
- Article
GLOBAL WARMING AND CARBON-NEGATIVE TECHNOLOGY: PROSPECTS FOR A LOWER-COST ROUTE TO A LOWER RISK ATMOSPHERE.
- Published in:
- Energy & Environment, 2009, v. 20, n. 6, p. 973, doi. 10.1260/095830509789625374
- By:
- Publication type:
- Article
Outcomes in Patients With Non-small-cell Lung Cancer With Brain Metastases Treated With Pembrolizumab-based Therapy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Effect of Prophylactic Cranial Irradiation on Overall Survival in Metastatic Small-Cell Lung Cancer: A Propensity Score-Matched Analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Etirinotecan Pegol (NKTR-102) in Third-line Treatment of Patients With Metastatic or Recurrent Non-Small-cell Lung Cancer: Results of a Phase II Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The Role of Advanced Imaging in Assessing Response to Definitive Chemoradiation Before Prophylactic Cranial Irradiation in Limited-Stage Small-Cell Lung Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Pretreatment Red Blood Cell Total Folate Concentration Is Associated With Response to Pemetrexed in Stage IV Nonsquamous Non-Small-cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck.
- Published in:
- Current Oncology Reports, 2008, v. 10, n. 2, p. 176, doi. 10.1007/s11912-008-0027-6
- By:
- Publication type:
- Article
A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The Middle East in 2020.
- Published in:
- 2020
- By:
- Publication type:
- Proceeding
Single-Institution Experience of Larotrectinib Therapy for Patients With NTRK Fusion-Positive Thyroid Carcinoma.
- Published in:
- Journal of the Endocrine Society, 2024, v. 8, n. 10, p. 1, doi. 10.1210/jendso/bvae158
- By:
- Publication type:
- Article
Phase II Trial of CDX-3379 and Cetuximab in Recurrent/Metastatic, HPV-Negative, Cetuximab-Resistant Head and Neck Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2355, doi. 10.3390/cancers14102355
- By:
- Publication type:
- Article
Functional Outcomes in Patients with Human Papillomavirus‐Associated Oropharyngeal Squamous Cell Cancer Treated with Trimodality Therapy.
- Published in:
- Laryngoscope, 2023, v. 133, n. 11, p. 3013, doi. 10.1002/lary.30714
- By:
- Publication type:
- Article
Locoregional Recurrence in p16‐Positive Oropharyngeal Squamous Cell Carcinoma After TORS.
- Published in:
- Laryngoscope, 2021, v. 131, n. 12, p. E2865, doi. 10.1002/lary.29659
- By:
- Publication type:
- Article
Acupuncture for Dyspnea in Lung Cancer.
- Published in:
- Integrative Cancer Therapies, 2016, v. 15, n. 3, p. 326, doi. 10.1177/1534735415624138
- By:
- Publication type:
- Article
Acupuncture for Dyspnea in Lung Cancer.
- Published in:
- Integrative Cancer Therapies, 2016, v. 15, n. 1, p. 1, doi. 10.1177/1534735415624138
- By:
- Publication type:
- Article
A phase 1, open-label, dose-escalation study of BIIB022 (anti-IGF-1R monoclonal antibody) in subjects with relapsed or refractory solid tumors.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 3, p. 518, doi. 10.1007/s10637-014-0064-y
- By:
- Publication type:
- Article
A phase I trial of KX2-391, a novel non-ATP competitive substrate-pocket- directed SRC inhibitor, in patients with advanced malignancies.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 4, p. 967, doi. 10.1007/s10637-013-9929-8
- By:
- Publication type:
- Article
A Phase I, open-label, dose escalation study of afatinib, in a 3-week-on/1-week-off schedule in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 2, p. 399, doi. 10.1007/s10637-012-9890-y
- By:
- Publication type:
- Article
Antiangiogenic therapy for advanced renal cell carcinoma: Management of treatment-related toxicities.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 5, p. 2066, doi. 10.1007/s10637-012-9796-8
- By:
- Publication type:
- Article
Petitioning for a revised statement on climate change.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Immunotherapy for head and neck cancer: latest developments and clinical potential.
- Published in:
- Therapeutic Advances in Medical Oncology, 2016, v. 8, n. 3, p. 168, doi. 10.1177/1758834016631529
- By:
- Publication type:
- Article
Use of the aromatase inhibitor anastrozole in the treatment of patients with advanced prostate carcinoma.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Impact of telemedicine adoption on accessibility and time to treatment in patients with thoracic malignancies during the COVID-19 pandemic.
- Published in:
- BMC Cancer, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12885-021-08819-z
- By:
- Publication type:
- Article
Fanconi anemia caused by biallelic inactivation of BRCA2 can present with an atypical cancer phenotype in adulthood.
- Published in:
- Clinical Genetics, 2023, v. 103, n. 1, p. 119, doi. 10.1111/cge.14231
- By:
- Publication type:
- Article
Exposure-response relationship for ramucirumab from the randomized, double-blind, phase 3 REVEL trial (docetaxel versus docetaxel plus ramucirumab) in second-line treatment of metastatic non-small cell lung cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Two Phase 1 dose-escalation studies exploring multiple regimens of litronesib (LY2523355), an Eg5 inhibitor, in patients with advanced cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 1047, doi. 10.1007/s00280-015-2705-z
- By:
- Publication type:
- Article
Sunitinib in combination with paclitaxel plus carboplatin in patients with advanced solid tumors: phase I study results.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 3, p. 703, doi. 10.1007/s00280-010-1536-1
- By:
- Publication type:
- Article
Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 945, doi. 10.1007/s00280-010-1377-y
- By:
- Publication type:
- Article
A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 1, p. 81, doi. 10.1007/s00280-006-0352-0
- By:
- Publication type:
- Article
A phase I study of the safety and pharmacokinetics of edotecarin (J-107088), a novel topoisomerase I inhibitor, in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 1, p. 139, doi. 10.1007/s00280-006-0267-9
- By:
- Publication type:
- Article
Overall Survival, Treatment Duration, and Rechallenge Outcomes With ICI Therapy for Recurrent or Metastatic HNSCC.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 8, p. e2428526, doi. 10.1001/jamanetworkopen.2024.28526
- By:
- Publication type:
- Article
Risk of Cardiovascular Events Among Patients With Head and Neck Cancer.
- Published in:
- JAMA Otolaryngology-Head & Neck Surgery, 2023, v. 149, n. 8, p. 717, doi. 10.1001/jamaoto.2023.1342
- By:
- Publication type:
- Article
Problems With Interpreting Treatment Effects in Observational Competing Risks Data—Reply.
- Published in:
- JAMA Otolaryngology-Head & Neck Surgery, 2023, v. 149, n. 2, p. 183, doi. 10.1001/jamaoto.2022.4038
- By:
- Publication type:
- Article